Home
Obi Profile
Fees
Services
News
Publications
Contact
You are here:
Title Details
Search
Login
Anti-P-selectin antibodies and methods of using the same to treat inflammatory diseases
No-Receipt date
2021-01341 - 06/04/2021
No-Filing date
20210800009 - 06/04/2021
No-Granting date
8000860 - 01/03/2022
No-EPO application date
-
No-EPO granting date
-
Gazette No-Publication date of application
8/2021 - 15/09/2021
Gazette No-Publication date of granted patent
3/2022 - 18/04/2022
Expiration date
01/12/2032
Kind of title
Supplementary Protection Certificate for Medicinal Products
Legal status
VALID
Priorities
-
Active Substance of Supplementary Certificates
CRIZANLIZUMAB
IPC Classification
Related Documents
Related Titles
Type
Master title
Related title
[SPC]
20180403557
Owners
Code
Firstname
Surname
Address
Town
ZIP
Country
928616
NOVARTIS AG
LICHTSTRASSE 35
4056 BASEL, SWITZERLAND
SWITZERLAND
867605
OKLAHOMA MEDICAL RESEARCH FOUNDATION
825 N.E. 13TH STREET,
OKLAHOMA CITY, OK 73104, U.S.A.
UNITED STATES OF AMERICA (USA)
Inventors
Code
Firstname
Surname
2343250
MCEVER, RODGER P.
2343251
ALVAREZ, RICHARD
2343252
KAWAR, ZIAD
Representatives
Code
Firstname
Surname
Address
Town
Zip
3089
NIKOLAOS
LYMPERIS "DIKIGORIKI ETAIREIA VAGIANOU KOSTOPOULOU LYMPERI"
STOURNARI 37
ATHINA (ATTIKIS)
10682
Contact
Code
Firstname
Surname
Address
Town
Zip
Country
7915
NIKOLAOS
LYMPERIS
STOURNARI 37
ATHINA (ATTIKIS)
10682
GREECE
Owners History
Title Instruments
Payments history
© OBI all rights reserved
designed & developed by PROFILE S.A.
Certified QMS :
EN ISO 9001:2015
and
ΕΝ ISO 14001:2015
The project "Internet technological information diffusion from industrial property titles" is co-financed 70% by the European Regional Development Found and 30% by the Hellenic public sector (Operational programme "Competitiveness", Measure 4.4).